EUVIMEDEUVIMED entdecken
Leserbrief

Overestimation of the drug-drug interaction risk between remimazolam and clopidogrel

Hisakazu Ohtani, Mao Inagaki

Drug Metabolism and Disposition · 2026-04 · 54 (4) · 100265

DOI: 10.1016/j.dmd.2026.100265 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Drug Metabolism and Disposition, 2026-04. Verfasst von Hisakazu Ohtani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Keio University, Minato, Tokyo, Japan; School of Medicine, Keio University, Shinjuku, Tokyo, Japan; Department of Pharmacy, Keio…. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Faculty of Pharmacy, Keio University, Minato, Tokyo, Japan; School of Medicine, Keio University, Shinjuku, Tokyo, Japan; Department of Pharmacy, Keio University Hospital, Shinjuku, Tokyo, Japan. Electronic address: ohta…
  • Faculty of Pharmacy, Keio University, Minato, Tokyo, Japan.

Zitieren

APA

Ohtani, H., & Inagaki, M. (2026). Overestimation of the drug-drug interaction risk between remimazolam and clopidogrel. Drug Metabolism and Disposition, 54(4), 100265. https://doi.org/10.1016/j.dmd.2026.100265

Vancouver

Ohtani H, Inagaki M. Overestimation of the drug-drug interaction risk between remimazolam and clopidogrel. Drug Metabolism and Disposition. 2026;54(4):100265. doi:10.1016/j.dmd.2026.100265

BibTeX
@article{Ohtani2026,
  author = {Ohtani, Hisakazu and Inagaki, Mao},
  title = {Overestimation of the drug-drug interaction risk between remimazolam and clopidogrel},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  volume = {54},
  number = {4},
  pages = {100265},
  doi = {10.1016/j.dmd.2026.100265}
}
Kostenlos starten →